NPI: 1790929826 · STOCKTON, CA 95210 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/20/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/20/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,704 | $1.64M |
| 2019 | 20,576 | $1.42M |
| 2020 | 17,866 | $1.34M |
| 2021 | 20,938 | $1.43M |
| 2022 | 18,042 | $1.52M |
| 2023 | 22,287 | $1.95M |
| 2024 | 15,873 | $1.82M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 51,345 | 4,935 | $11.10M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,391 | 2,154 | $10K |
| J1756 | Injection, iron sucrose, 1 mg | 7,477 | 2,074 | $2K |
| A4657 | Syringe, with or without needle, each | 4,195 | 2,784 | $2K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 887 | 520 | $1K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,007 | 1,612 | $610.03 |
| 90677 | 12 | 12 | $293.12 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 715 | 568 | $46.44 |
| 90674 | 47 | 47 | $7.82 | |
| 85041 | 2,160 | 1,978 | $1.46 | |
| 85048 | 2,141 | 1,960 | $1.24 | |
| 83540 | 1,185 | 1,113 | $0.00 | |
| 83970 | 1,678 | 1,598 | $0.00 | |
| 82108 | 191 | 182 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 322 | 294 | $0.00 |
| 90662 | 54 | 53 | $0.00 | |
| 85045 | 15 | 14 | $0.00 | |
| 82728 | 1,180 | 1,120 | $0.00 | |
| 83550 | 860 | 802 | $0.00 | |
| 0250 | 10,424 | 653 | $0.00 |